We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TFC:NYSETruist Financial Corporation Analysis

Data as of 2026-05-27 - not real-time

$48.37

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Truist Financial is trading in a clear bullish technical environment – the price sits above its short‑term and intermediate moving averages, volume is on the rise and the MACD histogram has turned positive while the RSI hovers near the midpoint, suggesting limited upside momentum risk. The stock also benefits from a supportive macro backdrop, with the Fear & Greed index indicating extreme greed and market sentiment broadly favorable.
Fundamentally, the company delivered a stronger‑than‑expected earnings beat, posted solid revenue growth, and maintains a profit margin that comfortably exceeds industry norms. Its price‑to‑earnings multiple is well below the sector average, while the dividend yield tops four percent with a payout ratio near half of earnings, indicating a sustainable income stream. Management’s recent commitment to raise ROTCE targets and expand the share‑buyback program adds further upside, even though a discounted cash‑flow model implies a modest over‑valuation relative to current pricing.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical setup with price above key moving averages
  • Increasing volume supporting upward momentum
  • Strong quarterly earnings beat and rising dividend yield

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Valuation advantage versus peer PE multiples
  • Management’s enhanced ROTCE guidance and sizable buyback authorization
  • Analyst price targets indicating meaningful upside potential

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustainable dividend income with a moderate payout ratio
  • Stable earnings and cash flow generation in a regulated banking environment
  • Valuation appears broadly fair, limiting long‑term price appreciation

Key Metrics & Analysis

Financial Health

Revenue Growth5.20%
Profit Margin29.62%
P/E Ratio12.0
ROE8.58%
ROA1.02%
P/B Ratio1.0
Op. Cash Flow$5.7B
Industry P/E16.6

Technical Analysis

TrendBullish
RSI48.8
Support$46.24
Resistance$51.58
MA 20$48.68
MA 50$48.22
MA 200$47.59
MACDBullish
VolumeIncreasing
Fear & Greed Index92.09

Valuation

Fair Value$31.54
Target Price$55.67
Upside/Downside15.09%
GradeFair
TypeBlend
Dividend Yield4.27%

Risk Assessment

Beta1.00
Volatility22.00%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.